Director, Clinical Data Management Revolution Medicines, Inc.Director, Clinical Data ManagementRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Associate Director, Clinical Quality Assurance Revolution Medicines, Inc.Associate Director, Clinical Quality AssuranceRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Biostatistics Clinical Late Stage Revolution Medicines, Inc.Associate Director, Biostatistics Clinical Late StageRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Clinical Laboratory Scientist, Oncology (PM Shift) BillionToOneClinical Laboratory Scientist, Oncology (PM Shift)Menlo Park, CA$59.14–$67.29 / hourAt BillionToOne, we've built a category-defining, publicly traded company on Nasdaq where transparency fuels trust, collaboration drives breakthroughs, and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all. Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne’s Fetal Cell Capture Technology.
Clinical Laboratory Scientist, Prenatal BillionToOneClinical Laboratory Scientist, PrenatalUnion City, CA$59.14–$86.97 / hourWe are looking for driven Clinical Laboratory Scientists (with California Clinical Laboratory Scientist License) to perform UNITY, the only non-invasive prenatal test (NIPT) that can detect inherited disorders such as sickle cell disease, spinal muscular atrophy, and cystic fibrosis in the baby directly from maternal blood. At BillionToOne, we've built a category-defining, publicly traded company on Nasdaq where transparency fuels trust, collaboration drives breakthroughs, and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all.
Associate Director, Clinical Data Management Revolution Medicines, Inc.Associate Director, Clinical Data ManagementRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Director, Biostatistics, Late Clinical Stage Revolution Medicines, Inc.Director, Biostatistics, Late Clinical StageRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and studies in clinical late-stage development and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle.
Executive Director, Clinical Supply Chain Revolution Medicines, Inc.Executive Director, Clinical Supply ChainRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Clinical Supply Chain Revolution Medicines, Inc.Associate Director, Clinical Supply ChainRedwood City, CA$186,000–$233,000 / yearLead and manage clinical supply and logistics activities, for blinded as well as open label studies, including but not limited to: demand forecasting and supply planning, IRT start-up and maintenance, label generation and approval, packaging and labeling operations, release and distribution, expiry extension, cold chain management, and inventory management. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Senior Manager, Analytical AI Clinical Development Bristol Myers SquibbSenior Manager, Analytical AI Clinical DevelopmentBrisbane, CA$167,370–$202,807 / yearAligned with Bristol Myers Squibb's mission to advance clinical development through data-driven innovation, the Senior Manager- Analytical AI in Clinical Development will play a key role in designing and deploying machine learning pipelines to optimize clinical trial operations. Stay Ahead of AI Trends in Clinical Development: Continuously evaluate emerging trends and advancements in data science and AI, integrating cutting-edge techniques such as natural language processing (NLP) and predictive analytics into clinical trial workflows.
Global Clinical Trial Leader (Hybrid) Dawar ConsultingGlobal Clinical Trial Leader (Hybrid)South San Francisco, CaliforniaPartner with cross-functional teams, vendors, and stakeholders to ensure successful study execution, risk management, operational excellence, and compliance with GCP/ICH and regulatory requirements. Provide operational leadership and guidance to global cross-functional Protocol Execution Teams (PETs) across study start-up, conduct, and close-out activities.
Clinical Manager - Home Health Pathways HealthcareClinical Manager - Home HealthConcord, CaliforniaLead and support the Center's clinical team, providing day-to-day guidance, coaching, and problem-solving to help clinicians deliver exceptional patient care. Maintain clinical competency and provide patient or joint visits when needed to support patients and team members.
NewPrin. Clinical Specialist, Superficial Venous Interventions (SVI) - Sacramento, CA/San Francisco, CA MedtronicPrin. Clinical Specialist, Superficial Venous Interventions (SVI) - Sacramento, CA/San Francisco, CASan Francisco, CaliforniaThe following benefits and additional compensation are available to those regular employees who work 20+ hours per week: Health, Dental and vision insurance, Health Savings Account, Healthcare Flexible Spending Account, Life insurance, Long-term disability leave, Dependent daycare spending account, Tuition assistance/reimbursement, and Simple Steps (global well-being program). If you are applying to perform work for Medtronic, Inc. (“Medtronic”) in any position which will involve performing at least two (2) hours of work on average each week within the unincorporated areas of Los Angeles County, you can find here a list of all material job duties of the specific job position which Medtronic reasonably believes that criminal history may have a direct, adverse and negative relationship potentially resulting in the withdrawal of a conditional offer of employment.
Clinical Supervisor AbodeClinical SupervisorVallejo, CaliforniaThe team will engage, house, and provide wrap-around clinical services to the chronically homeless, vulnerable individuals who have Serious Mental Health Disorders, Substance Use Disorders, and/or Chronic Health Conditions.⯠This position will be responsible for assessing the mental health needs of referred individuals living in the County, in the office and at housing sites, as well as clinical supervision to ASWs and MFTs who are working towards licensure.â¯. Experience, understanding and ability to implement theories of biological, psychological, and social development This includes, but is not limited to, an understanding of human behavior and psychopathology, human diversity, interpersonal relationships and family dynamics, mental disorders, stress, and chemical dependency.
Manager, Clinical Workforce Utilization (Scheduling Manager) HealthFlex Home Health ServicesManager, Clinical Workforce Utilization (Scheduling Manager)Oakland, CAThe Manager serves as the central point of coordination between Talent Acquisition, Clinical Leadership, Care Coordinators, and the Intake team, resolving daily field escalations, diagnosing staffing barriers, and driving process improvements that keep caseloads balanced and productivity targets on track. This is a highly cross-functional, data-informed operational role: part air-traffic-control for daily field issues, part analyst building the reporting infrastructure that makes staffing gaps and trends visible before they become problems.
Global Development Lead (Gdl), Clinical Development Revolution Medicines, Inc.Global Development Lead (Gdl), Clinical DevelopmentRedwood City, CA$369,000–$424,000 / yearPartner closely with the Project Team Leader (PTL) or Lifecycle Team Leader (LCL) to ensure that clinical development strategy, positions and decision-making are fully represented and integrated within lifecycle planning and decision-making for the molecule, with clear alignment on roles, decision rights and accountability. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Medical Director, Clinical Development - Oncology Lyell Immunopharma, Inc.Medical Director, Clinical Development - OncologySouth San Francisco, CA$240,000–$300,000 / yearThis individual contributor role is responsible for providing medical and scientific leadership across one or more clinical trials, supporting protocol development, regulatory interactions, and data interpretation as Lyell advances toward its first approval and commercial launch. At Lyell, we believe that highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other.
Senior Director, Clinical Operations Pliant Therapeutics, Inc.Senior Director, Clinical OperationsSouth San Francisco, CA$289,000–$320,000 / yearWe believe our platform may be broadly applicable across multiple disease areas including delivery of drug payloads to cells utilizing integrin receptor-binding molecules as tissue-specific delivery and internalization mechanisms. Currently, Pliant is conducting a Phase 1 study of PLN-101095, a small molecule, dual-selective inhibitor of vß8 and vß1 integrins, that has shown encouraging clinical activity in the development of a treatment of immune checkpoint resistant solid tumors.
Senior Director Of Clinical Nutrition Services Stanford Health CareSenior Director Of Clinical Nutrition ServicesPalo Alto, CA$94.35–$125.03 / hourLeads the expansion of inpatient, outpatient nutrition services, and virtual nutrition programs while driving innovation and new care models including digital health, population health nutrition, and specialty nutrition programs (i.e., oncology, transplant, metabolic health, and other chronic diseases). It hosts the region's only Level I trauma center between San Francisco and San Jose, is a Magnet-designated organization since 2007, carries Joint Commission accreditation and a Five-Star CMS rating, and has earned Vizient awards and repeated U.S. News Honor Roll recognition.
Senior Clinical Scientist Jade BiosciencesSenior Clinical ScientistSan Francisco, CaliforniaRemote$175,000–$190,000 / yearJade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases.